Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Single Center Study to Evaluate the Efficacy and Safety of Tenofovir Alafenamide Conversion in Liver Transplant Patients

NCT06589518 is registered in ClinicalTrials.gov with Jongman Kim as lead sponsor.

NCT NCT06589518
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06589518 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Single Center Study to Evaluate the Efficacy and Safety of Tenofovir Alafenamide Conversion in Liver Transplant Patients
Lead sponsor
Jongman Kim
Phase
Phase 2
Overall status
Not yet recruiting
Start date
March 1, 2025
Completion date
June 30, 2026
Enrollment
108 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b virus, liver transplant, renal insufficiency